STOCK TITAN

Abacus Life, Inc. - ABL STOCK NEWS

Welcome to our dedicated page for Abacus Life news (Ticker: ABL), a resource for investors and traders seeking the latest updates and insights on Abacus Life stock.

Abacus Life, Inc. (NASDAQ: ABL) is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy. Established in 2004, the company has carved a niche in the life settlement market, having purchased life insurance policies with over $5 billion in face value. Abacus Life serves consumers seeking liquidity by actively managing these policies through trading, holding, or servicing.

Abacus Life stands out for its detailed, data-driven approach to actuarial technology, democratizing the life insurance space via three key channels: ABL Tech, ABL Wealth, and ABL Longevity Growth & Income Funds. ABL Tech focuses on leveraging AI and innovative technology to enhance data security and operational efficiency, while ABL Wealth and ABL Longevity Funds offer tailored wealth management and investment solutions.

The company has achieved significant milestones, such as its recent $15 million stock repurchase program and the appointment of notable industry experts to its leadership team. They lead the market in funds paid to clients, holding a 26% market share in 2023, paying over $220 million to policyholders.

Abacus Life’s financial stability is evident in its impressive revenue growth, with total revenues for Q1 2024 doubling to $21.5 million compared to the previous year. They also maintain strong relationships with 78 institutional partners and 30,000 financial advisors and are accredited by the BBB with an A+ rating.

With operations in 49 states, Abacus Life is committed to maintaining the confidentiality of personal information, complying with HIPAA and privacy laws. Their stock is publicly traded on the Nasdaq Exchange under the ticker symbol ABL.

For more detailed information, visit their website at www.Abacuslife.com.

Rhea-AI Summary

Abacus Life has successfully closed its oversubscribed public offering, raising gross proceeds of $92 million by selling 11,500,000 shares of common stock at $8.00 per share. This includes the full exercise of the underwriters' option to purchase an additional 1,500,000 shares. The funds will support corporate operations, including buying life settlement policies, business strategies, working capital, and possibly repaying or refinancing debt. Piper Sandler, TD Securities, B. Riley Securities, and KKR Capital Markets acted as joint book-running managers. The offering's registration statement was declared effective by the SEC on June 20, 2024, and the final prospectus was filed on June 21, 2024.

This announcement does not constitute an offer to sell or a solicitation to buy these securities in any jurisdiction where such activities would be unlawful.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.65%
Tags
-
Rhea-AI Summary

Abacus Life (NASDAQ: ABL) has announced the pricing of its oversubscribed public offering of 10,000,000 shares at $8.00 per share.

The gross proceeds are expected to be approximately $80 million, excluding the underwriters' 30-day option to purchase an additional 1,500,000 shares. The offering is anticipated to close on June 24, 2024, subject to customary conditions.

Abacus plans to utilize the net proceeds for operations, including purchasing life settlement policies, supporting its business strategy, working capital, and potentially repaying or refinancing indebtedness.

Piper Sandler & Co., TD Securities (USA) , B. Riley Securities, and KKR Capital Markets are acting as joint book-running managers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.71%
Tags
-
Rhea-AI Summary

Abacus Life (NASDAQ: ABL) has initiated a public offering of 10,000,000 shares of its common stock, aiming to raise capital.

The offering includes an option for underwriters to purchase an additional 1,500,000 shares within 30 days.

Proceeds will be used for operational needs, business strategy support, working capital, and potentially repaying debt.

The offering's completion is subject to market conditions, with Piper Sandler & Co., TD Securities, B. Riley Securities, and KKR Capital Markets acting as joint book-running managers.

A registration statement has been filed with the SEC but isn't effective yet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.23%
Tags
Rhea-AI Summary

Abacus Life (NASDAQ: ABL) announced that it led the life settlement industry in 2023 with a 26% market share in funds paid to clients, according to The Deal's annual ranking.

The company paid $220 million in life settlement funds, equivalent to over 20% of policy face value on average, which is 32% higher than its closest competitor.

Additionally, Abacus acquired 640 policies with a collective face value of nearly $1.1 billion, reflecting a 31.4% increase from 2022, compared to the industry growth of 4%.

CEO Jay Jackson expressed pride in the company's achievements and commitment to delivering exceptional value to clients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.08%
Tags
none
-
Rhea-AI Summary

Abacus Life (NASDAQ: ABL), a leader in alternative asset management, announced a new national distribution agreement with AIMCOR, a top insurance marketing organization. This relationship enables Abacus to offer life settlement solutions through AIMCOR’s network of 40+ brokerage general agencies. Abacus CEO Jay Jackson highlighted the partnership's potential to help AIMCOR members leverage Abacus' resources, fostering better financial decisions for policyholders. AIMCOR's EVP, Marc Verbos, emphasized the collaboration's role in promoting life settlements as a mainstream financial solution, enhancing the strategic growth and education of financial professionals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.8%
Tags
none
-
Rhea-AI Summary

Abacus Life, Inc. reported a more than doubled total revenue of $21.5 million in the first quarter of 2024, driven by a 59% year-over-year growth in the Direct-to-Consumer division. The company also launched ABL Tech, raised $25 million from the issuance of senior notes, and strengthened its management team. Adjusted EBITDA grew by 38.1% to $11.6 million, with an EBITDA margin of 53.9%. Despite a GAAP net loss of $1.3 million, adjusted net income was $6.7 million. The company had cash equivalents of $65.4 million and repurchased shares worth $11 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.17%
Tags
Rhea-AI Summary
Abacus Life, Inc. appoints Fei Xue as Vice President of ABL Wealth, bringing nearly two decades of experience in asset and wealth management. ABL Wealth aims for aggressive expansion with unique lifespan-driven financial planning and investment offerings. Fei Xue's background includes strategic advisory roles at Dynasty Financial Partners and CNL Financial Group, with a focus on alternative assets and the RIA community. The partnership between ABL Wealth and Dynasty Financial Partners is set to drive exponential growth in the independent wealth management space.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
management
-
Rhea-AI Summary
Abacus Life, Inc. (ABL) will release its First Quarter 2024 financial results on May 13, 2024, followed by a conference call. The company specializes in buying life insurance policies and alternative asset management. Investors can access the webcast on Abacus' investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.28%
Tags
-
Rhea-AI Summary
Abacus Life, Inc. (ABL) appoints Elena Plesco as Chief Capital Officer to enhance capital management and global expansion. Ms. Plesco brings extensive investing experience from KKR and J.P. Morgan, aiming to optimize financial structure and drive long-term growth for Abacus.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.72%
Tags
none
Rhea-AI Summary
Abacus Life, Inc. reported strong financial results for the fourth quarter and full year 2023, with total revenue growing 25% year-over-year to $23.6 million in Q4 and $79.6 million for the full year. Originations capital deployment increased by 92% to $68.3 million in Q4 and by 46% to $218.9 million for the full year. The company also authorized a $15 million stock repurchase program and completed a public bond offering to reduce debt and lower interest rates. Despite a GAAP net loss in Q4 due to non-cash expenses, the company remains optimistic about sustained growth and value creation for stockholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags

FAQ

What is the current stock price of Abacus Life (ABL)?

The current stock price of Abacus Life (ABL) is $8.34 as of November 15, 2024.

What is the market cap of Abacus Life (ABL)?

The market cap of Abacus Life (ABL) is approximately 613.9M.

What does Abacus Life, Inc. specialize in?

Abacus Life specializes in investing and managing life insurance products throughout the lifecycle of a policy.

What recent achievements has Abacus Life accomplished?

Abacus Life has recently led the industry in funds paid to clients with a 26% market share in 2023 and launched several strategic initiatives including a $15 million stock repurchase program.

How is Abacus Life democratizing the life insurance space?

Abacus Life is democratizing the life insurance space through its innovative channels: ABL Tech, ABL Wealth, and ABL Longevity Growth & Income Funds, leveraging data-driven technology and strategic wealth management.

What are Abacus Life's financial highlights for Q1 2024?

For Q1 2024, Abacus Life reported a total revenue of $21.5 million, more than doubling from the previous year, driven by higher active management revenue and increased policy originations.

Who are the recent key hires at Abacus Life?

Recent key hires include Elena Plesco as Chief Capital Officer and Fei Xue as Vice President of ABL Wealth, both bringing significant experience in asset management and investment.

What makes Abacus Life unique in the life settlement industry?

Abacus Life is the only public life settlement company, providing exceptional value to clients with a market-leading rate of over 20% of policy face value paid to sellers.

How does Abacus Life ensure the confidentiality of personal information?

Abacus Life complies with HIPAA and privacy laws to maintain and protect the confidentiality of financial, health, and medical information.

Where is Abacus Life's stock traded?

Abacus Life's stock is publicly traded on the Nasdaq Exchange under the ticker symbol ABL.

What is Abacus Life's approach to technology and innovation?

Abacus Life leverages AI and innovative technology through ABL Tech to introduce advanced solutions like AI-driven death verification, valuation services, and a blockchain-based marketplace.

What partnerships does Abacus Life have to enhance its distribution network?

Abacus Life has formed a new national distribution relationship with AIMCOR, enhancing their ability to offer life settlement solutions to a broad network of financial professionals and clients.

Abacus Life, Inc.

Nasdaq:ABL

ABL Rankings

ABL Stock Data

613.86M
74.68M
82.88%
17.39%
0.9%
Insurance - Life
Investment Advice
Link
United States of America
ORLANDO